Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 114

1.
2.

Absence of Drug-Drug Interaction of Anastrozole on Levonorgestrel Delivered Simultaneously by an Intravaginal Ring: Results of a Phase 2 Trial.

Nave R, Mellinger U, Klein S, Höchel J, Schmitz H.

J Clin Pharmacol. 2019 Jul;59(7):1022-1028. doi: 10.1002/jcph.1396. Epub 2019 Feb 21.

3.

Monoclonal Antibody Against Prolactin Receptor: A Randomized Placebo-Controlled Study Evaluating Safety, Tolerability, and Pharmacokinetics of Repeated Subcutaneous Administrations in Postmenopausal Women.

Nave R, Jodl S, Hoffmann A, Gashaw I, Zollmann F, Berse M, Höchel J, Krätzschmar J, Rohde B.

Reprod Sci. 2019 Apr;26(4):523-531. doi: 10.1177/1933719118776806. Epub 2018 May 27.

PMID:
29806538
4.

[THE NATIONAL FINAL INTERNAL MEDICINE EXAMINATION SCORE - IS IT PREDICTABLE?]

Nave R, Umansky T, Ber R, Azzam Z, Karban A.

Harefuah. 2018 Jan;157(1):11-15. Hebrew.

PMID:
29374866
5.

Effect of forage species and supplement type on rumen kinetics and serum metabolites in growing beef heifers grazing winter forage.

McFarlane ZD, Barbero RP, Nave RLG, Maheiros EB, Reis RA, Mulliniks JT.

J Anim Sci. 2017 Dec;95(12):5301-5308. doi: 10.2527/jas2017.1780.

6.

Medical students' attitudes towards participating in a palliative medicine course: A new specialty in Israel.

Bar-Sela G, Mitnik I, Zalman D, Flechter E, Sheinman-Yuffe H, Vulfsons S, Postovsky S, Smolin B, Nave R, Azzam ZS.

Palliat Support Care. 2018 Oct;16(5):528-533. doi: 10.1017/S1478951517000943. Epub 2017 Dec 4.

PMID:
29198227
7.

The Effect of Drug Content Reduction on the In Vitro and In Vivo Properties of Levonorgestrel-Releasing Intravaginal Rings.

Nave R, Jalkanen T, Talling C, Kaneko M, Matsuki S, Höchel J.

J Pharm Sci. 2018 Apr;107(4):1020-1027. doi: 10.1016/j.xphs.2017.11.009. Epub 2017 Nov 23.

PMID:
29175414
8.

Absence of Effect of Intravaginal Miconazole, Clindamycin, Nonoxynol-9, and Tampons on the Pharmacokinetics of an Anastrozole/Levonorgestrel Intravaginal Ring.

Nave R, Klein S, Müller A, Chang X, Höchel J.

J Clin Pharmacol. 2018 Jan;58(1):97-106. doi: 10.1002/jcph.984. Epub 2017 Aug 7.

9.

Model-Based Dose Selection for Intravaginal Ring Formulations Releasing Anastrozole and Levonorgestrel Intended for the Treatment of Endometriosis Symptoms.

Reinecke I, Schultze-Mosgau MH, Nave R, Schmitz H, Ploeger BA.

J Clin Pharmacol. 2017 May;57(5):640-651. doi: 10.1002/jcph.846. Epub 2016 Dec 7.

PMID:
27925651
10.

Medical education in Israel 2016: five medical schools in a period of transition.

Reis S, Urkin J, Nave R, Ber R, Ziv A, Karnieli-Miller O, Meitar D, Gilbey P, Mevorach D.

Isr J Health Policy Res. 2016 Sep 15;5:45. doi: 10.1186/s13584-016-0104-5. eCollection 2016.

11.

Pharmacokinetics, pharmacodynamics, safety and tolerability of an intravaginal ring releasing anastrozole and levonorgestrel in healthy premenopausal women: a Phase 1 randomized controlled trial.

Schultze-Mosgau MH, Waellnitz K, Nave R, Klein S, Kraetzschmar J, Rautenberg T, Schmitz H, Rohde B.

Hum Reprod. 2016 Aug;31(8):1713-22. doi: 10.1093/humrep/dew145. Epub 2016 Jun 19.

PMID:
27390369
12.

Regional Cerebral Disease Progression in Friedreich's Ataxia: A Longitudinal Diffusion Tensor Imaging Study.

Mascalchi M, Toschi N, Giannelli M, Ginestroni A, Della Nave R, Tessa C, Piacentini S, Dotti MT, Aiello M, Nicolai E, Soricelli A, Salvi F, Diciotti S.

J Neuroimaging. 2016 Mar-Apr;26(2):197-200. doi: 10.1111/jon.12270. Epub 2015 Jul 14.

PMID:
26175281
13.

FORAGES AND PASTURES SYMPOSIUM: Improving efficiency of production in pasture- and range-based beef and dairy systems.

Mulliniks JT, Rius AG, Edwards MA, Edwards SR, Hobbs JD, Nave RL.

J Anim Sci. 2015 Jun;93(6):2609-15. doi: 10.2527/jas.2014-8595.

PMID:
26115249
14.

Progression of microstructural damage in spinocerebellar ataxia type 2: a longitudinal DTI study.

Mascalchi M, Toschi N, Giannelli M, Ginestroni A, Della Nave R, Nicolai E, Bianchi A, Tessa C, Salvatore E, Aiello M, Soricelli A, Diciotti S.

AJNR Am J Neuroradiol. 2015 Jun;36(6):1096-101. doi: 10.3174/ajnr.A4343. Epub 2015 Apr 16.

15.

Utility of a population pharmacokinetic meta analysis during the approval process of teduglutide for the treatment of short bowel syndrome.

Roepcke S, Nave R, Cyran J, Plock N, Lahu G, Facius A.

Int J Clin Pharmacol Ther. 2014 Dec;52(12):1045-58. doi: 10.5414/CP201942.

PMID:
25066226
16.

Raves for the emergency response to marathon bombings: Special report highlights prescient preparation.

Nave RL.

Ann Emerg Med. 2014 May;63(5):A13-4. No abstract available.

PMID:
24864356
17.

Baby boomers and the hepatitis C boom.

Nave RL.

Ann Emerg Med. 2013 Dec;62(6):19A-21A. No abstract available.

PMID:
24400356
18.

[Medical students' views on the use of virtual patients for teaching and assessment of clinical knowledge and reasoning].

Oliven A, Nave R, Hasson-Gilad DR, Baruch A.

Harefuah. 2013 May;152(5):257-61, 310. Hebrew.

PMID:
23885447
19.

Faster absorption and higher systemic bioavailability of intranasal fentanyl spray compared to oral transmucosal fentanyl citrate in healthy subjects.

Nave R, Schmitt H, Popper L.

Drug Deliv. 2013 Jun-Jul;20(5):216-23. doi: 10.3109/10717544.2012.762435. Epub 2013 May 8.

PMID:
23650968
20.

An innovative phase I population pharmacokinetic approach to investigate the pharmacokinetics of an intranasal fentanyl spray in healthy subjects.

Plock N, Facius A, Hartmann L, Baumann S, Nave R.

Int J Clin Pharmacol Ther. 2013 Jun;51(6):495-508. doi: 10.5414/CP201867.

PMID:
23611571
21.

From inhaler to lung: clinical implications of the formulations of ciclesonide and other inhaled corticosteroids.

Nave R, Mueller H.

Int J Gen Med. 2013;6:99-107. doi: 10.2147/IJGM.S39134. Epub 2013 Mar 7.

22.

Cerebellar hyperperfusion in semantic dementia.

Vella A, Della Nave R, Vetrugno R, Diciotti S, Boschi S, Banci Bonamici F, Mascalchi M.

Neurocase. 2014 Apr;20(2):175-82. doi: 10.1080/13554794.2012.741255. Epub 2013 Feb 15.

PMID:
23414345
23.

Pharmacokinetics of teduglutide in subjects with renal impairment.

Nave R, Halabi A, Herzog R, Schaffer P, Diefenbach J, Krause S, Berghöfer P, Lahu G, Hartmann M.

Eur J Clin Pharmacol. 2013 May;69(5):1149-55. doi: 10.1007/s00228-012-1455-7. Epub 2012 Nov 28.

PMID:
23187965
24.

Association between human parainfluenza virus type 1 and smoking history in patients with an abdominal aortic aneurysm.

Garrafa E, Marengoni A, Nave RD, Caimi L, Cervi E, Giulini SM, Imberti L, Bonardelli S.

J Med Virol. 2013 Jan;85(1):99-104. doi: 10.1002/jmv.23439. Epub 2012 Oct 23.

PMID:
23097301
25.

Single-dose and multi-dose delivery systems for intranasal fentanyl spray are bioequivalent as demonstrated in a replicate pharmacokinetic study.

Nave R, Connolly SM, Popper L, Lahu G, Schmitt H.

Int J Clin Pharmacol Ther. 2012 Oct;50(10):751-9. doi: 10.5414/CP201729.

PMID:
22943926
26.

Population pharmacokinetic meta-analysis of intranasal fentanyl spray as a means to enrich pharmacokinetic information for patients with cancer breakthrough pain.

Kaessner N, Nave R, Roepcke S, Facius A, Lahu G.

Int J Clin Pharmacol Ther. 2012 Sep;50(9):665-77. doi: 10.5414/CP201737.

PMID:
22784611
27.

A Thorough QT Study of Teduglutide in Healthy Subjects.

Hartmann M, Timmer W, Schultz A, Nave R, Luehmann R, Krause S, Lahu G, Scholpp J.

Clin Pharmacol Drug Dev. 2012 Apr;1(2):57-66. doi: 10.1177/2160763X12438745.

PMID:
27121220
28.
29.

Neurodegeneration in friedreich's ataxia is associated with a mixed activation pattern of the brain. A fMRI study.

Ginestroni A, Diciotti S, Cecchi P, Pesaresi I, Tessa C, Giannelli M, Della Nave R, Salvatore E, Salvi F, Dotti MT, Piacentini S, Soricelli A, Cosottini M, De Stefano N, Mascalchi M.

Hum Brain Mapp. 2012 Aug;33(8):1780-91. doi: 10.1002/hbm.21319. Epub 2011 Jun 14.

PMID:
21674694
30.

An investigation of the pharmacokinetics, pharmacodynamics, safety, and tolerability of ciclesonide hydrofluoroalkane nasal aerosol in healthy subjects and subjects with perennial allergic rhinitis.

Ratner P, Wingertzahn MA, Herzog R, Huang H, Desai SY, Maier G, Nave R.

Pulm Pharmacol Ther. 2011 Aug;24(4):426-33. doi: 10.1016/j.pupt.2011.04.002. Epub 2011 Apr 8.

PMID:
21501692
31.

Can outcome-based continuing medical education improve performance of immigrant physicians?

Castel OC, Ezra V, Alperin M, Nave R, Porat T, Golan AC, Vinker S, Karkabi K.

J Contin Educ Health Prof. 2011 Winter;31(1):34-42. doi: 10.1002/chp.20099.

PMID:
21425358
32.

Axial diffusivity is increased in the degenerating superior cerebellar peduncles of Friedreich's ataxia.

Della Nave R, Ginestroni A, Diciotti S, Salvatore E, Soricelli A, Mascalchi M.

Neuroradiology. 2011 May;53(5):367-72. doi: 10.1007/s00234-010-0807-1. Epub 2010 Dec 3.

PMID:
21128070
33.

Determination of lung deposition following inhalation of ciclesonide using different bioanalytical procedures.

Nave R.

Bioanalysis. 2010 Apr;2(4):807-14. doi: 10.4155/bio.10.21. Review.

PMID:
21083275
34.

Magnetization transfer MR imaging demonstrates degeneration of the subcortical and cortical gray matter in Huntington disease.

Ginestroni A, Battaglini M, Diciotti S, Della Nave R, Mazzoni LN, Tessa C, Giannelli M, Piacentini S, De Stefano N, Mascalchi M.

AJNR Am J Neuroradiol. 2010 Nov;31(10):1807-12. doi: 10.3174/ajnr.A2225. Epub 2010 Sep 2.

35.
36.

Patching improves perfusion of the sagged brain in intracranial hypotension.

Vetrugno R, Vella A, Mascalchi M, Della Nave R, Ginestroni A, Gallassi R, Montagna P.

J Neurol. 2011 Jan;258(1):146-8. doi: 10.1007/s00415-010-5681-6. Epub 2010 Aug 1. No abstract available.

PMID:
20680323
37.

Assessment of brain white matter fiber bundle atrophy in patients with Friedreich ataxia.

Pagani E, Ginestroni A, Della Nave R, Agosta F, Salvi F, De Michele G, Piacentini S, Filippi M, Mascalchi M.

Radiology. 2010 Jun;255(3):882-9. doi: 10.1148/radiol.10091742.

PMID:
20501725
38.

Regional distribution and clinical correlates of white matter structural damage in Huntington disease: a tract-based spatial statistics study.

Della Nave R, Ginestroni A, Tessa C, Giannelli M, Piacentini S, Filippi M, Mascalchi M.

AJNR Am J Neuroradiol. 2010 Oct;31(9):1675-81. doi: 10.3174/ajnr.A2128. Epub 2010 May 20.

39.

Deposition and metabolism of inhaled ciclesonide in the human lung.

Nave R, Watz H, Hoffmann H, Boss H, Magnussen H.

Eur Respir J. 2010 Nov;36(5):1113-9. doi: 10.1183/09031936.00172309. Epub 2010 Mar 29.

40.

Population pharmacokinetics and pharmacodynamics of inhaled ciclesonide and fluticasone propionate in patients with persistent asthma.

Xu J, Nave R, Lahu G, Derom E, Derendorf H.

J Clin Pharmacol. 2010 Oct;50(10):1118-27. doi: 10.1177/0091270009354994. Epub 2010 Feb 11.

PMID:
20150524
42.
43.

Peduncular hallucinosis: a polysomnographic and spect study of a patient and efficacy of serotonergic therapy.

Vetrugno R, Vella A, Mascalchi M, Alessandria M, D'Angelo R, Gallassi R, Della Nave R, Ginestroni A, Antelmi E, Montagna P.

Sleep Med. 2009 Dec;10(10):1158-60. doi: 10.1016/j.sleep.2009.05.005. Epub 2009 Jul 9.

PMID:
19592304
44.

Impact of cerebrospinal fluid contamination on brain metabolites evaluation with 1H-MR spectroscopy: a single voxel study of the cerebellar vermis in patients with degenerative ataxias.

Guerrini L, Belli G, Mazzoni L, Foresti S, Ginestroni A, Della Nave R, Diciotti S, Mascalchi M.

J Magn Reson Imaging. 2009 Jul;30(1):11-7. doi: 10.1002/jmri.21804.

PMID:
19557841
45.

Clinical pharmacokinetic and pharmacodynamic profile of inhaled ciclesonide.

Nave R.

Clin Pharmacokinet. 2009;48(4):243-52. doi: 10.2165/00003088-200948040-00002. Review.

PMID:
19492869
46.

Early structural changes in individuals at risk of familial Alzheimer's disease: a volumetry and magnetization transfer MR imaging study.

Ginestroni A, Battaglini M, Della Nave R, Moretti M, Tessa C, Giannelli M, Caffarra P, Nacmias B, Bessi V, Sorbi S, Bracco L, De Stefano N, Mascalchi M.

J Neurol. 2009 Jun;256(6):925-32. doi: 10.1007/s00415-009-5044-3. Epub 2009 Mar 1.

PMID:
19252791
47.

Brain white matter damage in SCA1 and SCA2. An in vivo study using voxel-based morphometry, histogram analysis of mean diffusivity and tract-based spatial statistics.

Della Nave R, Ginestroni A, Tessa C, Salvatore E, De Grandis D, Plasmati R, Salvi F, De Michele G, Dotti MT, Piacentini S, Mascalchi M.

Neuroimage. 2008 Oct 15;43(1):10-9. doi: 10.1016/j.neuroimage.2008.06.036. Epub 2008 Jul 11.

PMID:
18672073
48.

Brain structural damage in spinocerebellar ataxia type 1 : a VBM study.

Ginestroni A, Della Nave R, Tessa C, Giannelli M, De Grandis D, Plasmati R, Salvi F, Piacentini S, Mascalchi M.

J Neurol. 2008 Aug;255(8):1153-8. doi: 10.1007/s00415-008-0860-4. Epub 2008 Jun 13.

PMID:
18438695
50.

Brain structural damage in spinocerebellar ataxia type 2. A voxel-based morphometry study.

Della Nave R, Ginestroni A, Tessa C, Cosottini M, Giannelli M, Salvatore E, Sartucci F, De Michele G, Dotti MT, Piacentini S, Mascalchi M.

Mov Disord. 2008 Apr 30;23(6):899-903. doi: 10.1002/mds.21982.

PMID:
18311829

Supplemental Content

Support Center